165 related articles for article (PubMed ID: 32868820)
1. Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors.
Takayasu T; Shah M; Dono A; Yan Y; Borkar R; Putluri N; Zhu JJ; Hama S; Yamasaki F; Tahara H; Sugiyama K; Kurisu K; Esquenazi Y; Ballester LY
Sci Rep; 2020 Aug; 10(1):14326. PubMed ID: 32868820
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance of soluble c-kit in the cerebrospinal fluid of patients with germ cell tumors.
Miyanohara O; Takeshima H; Kaji M; Hirano H; Sawamura Y; Kochi M; Kuratsu J
J Neurosurg; 2002 Jul; 97(1):177-83. PubMed ID: 12134909
[TBL] [Abstract][Full Text] [Related]
3. Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy.
Ichimura K; Fukushima S; Totoki Y; Matsushita Y; Otsuka A; Tomiyama A; Niwa T; Takami H; Nakamura T; Suzuki T; Fukuoka K; Yanagisawa T; Mishima K; Nakazato Y; Hosoda F; Narita Y; Shibui S; Yoshida A; Mukasa A; Saito N; Kumabe T; Kanamori M; Tominaga T; Kobayashi K; Shimizu S; Nagane M; Iuchi T; Mizoguchi M; Yoshimoto K; Tamura K; Maehara T; Sugiyama K; Nakada M; Sakai K; Kanemura Y; Nonaka M; Asai A; Yokogami K; Takeshima H; Kawahara N; Takayama T; Yao M; Kato M; Nakamura H; Hama N; Sakai R; Ushijima T; Matsutani M; Shibata T; Nishikawa R;
Acta Neuropathol; 2016 Jun; 131(6):889-901. PubMed ID: 26956871
[TBL] [Abstract][Full Text] [Related]
4. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.
Satomi K; Takami H; Fukushima S; Yamashita S; Matsushita Y; Nakazato Y; Suzuki T; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Yoshimoto K; Tamura K; Maehara T; Sakai K; Sugiyama K; Yokogami K; Takeshima H; Nonaka M; Asai A; Ushijima T; Matsutani M; Nishikawa R; Ichimura K
Neuro Oncol; 2022 May; 24(5):834-846. PubMed ID: 34698864
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for Analyzing Circulating Tumor DNA in the Cerebrospinal Fluid in Patients with Central Nervous System Malignancies.
Shah M; Takayasu T; Zorofchian Moghadamtousi S; Arevalo O; Chen M; Lan C; Duose D; Hu P; Zhu JJ; Roy-Chowdhuri S; Riascos RF; Chen H; Luthra R; Esquenazi Y; Ballester LY
J Mol Diagn; 2021 Feb; 23(2):171-180. PubMed ID: 33531134
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignancies.
Zorofchian S; Iqbal F; Rao M; Aung PP; Esquenazi Y; Ballester LY
J Clin Pathol; 2019 Apr; 72(4):271-280. PubMed ID: 30467241
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 and PD-1 expression in pediatric central nervous system germ cell tumors.
Woods JK; Lidov HG; Ligon KL; Santagata S; Chi SN; Yeo KK; Alexandrescu S
Mod Pathol; 2022 Dec; 35(12):1770-1774. PubMed ID: 36057740
[TBL] [Abstract][Full Text] [Related]
8. A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.
Murray MJ; Bell E; Raby KL; Rijlaarsdam MA; Gillis AJ; Looijenga LH; Brown H; Destenaves B; Nicholson JC; Coleman N
Br J Cancer; 2016 Jan; 114(2):151-62. PubMed ID: 26671749
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid circulating tumour DNA as a liquid biopsy for central nervous system malignancies.
Escudero L; Martínez-Ricarte F; Seoane J
Curr Opin Neurol; 2020 Dec; 33(6):736-741. PubMed ID: 33177377
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors.
Ballester LY; Lu G; Zorofchian S; Vantaku V; Putluri V; Yan Y; Arevalo O; Zhu P; Riascos RF; Sreekumar A; Esquenazi Y; Putluri N; Zhu JJ
Acta Neuropathol Commun; 2018 Aug; 6(1):85. PubMed ID: 30170631
[TBL] [Abstract][Full Text] [Related]
11. Pediatric central nervous system germ cell tumors: a review.
Echevarría ME; Fangusaro J; Goldman S
Oncologist; 2008 Jun; 13(6):690-9. PubMed ID: 18586924
[TBL] [Abstract][Full Text] [Related]
12. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis.
Rimelen V; Ahle G; Pencreach E; Zinniger N; Debliquis A; Zalmaï L; Harzallah I; Hurstel R; Alamome I; Lamy F; Voirin J; Drénou B
Acta Neuropathol Commun; 2019 Mar; 7(1):43. PubMed ID: 30885253
[No Abstract] [Full Text] [Related]
14. Placental alkaline phosphatase levels in cerebrospinal fluid can have a decisive role in the differential diagnosis of intracranial germ cell tumors.
Aihara Y; Watanabe S; Amano K; Komatsu K; Chiba K; Imanaka K; Hori T; Ohba T; Dairoku H; Okada Y; Kubo O; Kawamata T
J Neurosurg; 2018 Sep; 131(3):687-694. PubMed ID: 30265190
[TBL] [Abstract][Full Text] [Related]
15. Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumors.
Takami H; Satomi K; Fukuoka K; Nakamura T; Tanaka S; Mukasa A; Saito N; Suzuki T; Yanagisawa T; Sugiyama K; Kanamori M; Kumabe T; Tominaga T; Tamura K; Maehara T; Nonaka M; Asai A; Yokogami K; Takeshima H; Iuchi T; Kobayashi K; Yoshimoto K; Sakai K; Nakazato Y; Matsutani M; Nagane M; Nishikawa R; Ichimura K
Sci Rep; 2023 Sep; 13(1):15760. PubMed ID: 37735187
[TBL] [Abstract][Full Text] [Related]
16. Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies.
Momtaz P; Pentsova E; Abdel-Wahab O; Diamond E; Hyman D; Merghoub T; You D; Gasmi B; Viale A; Chapman PB
Oncotarget; 2016 Dec; 7(51):85430-85436. PubMed ID: 27863426
[TBL] [Abstract][Full Text] [Related]
17. Validation of tumor markers in central nervous system germ cell tumors by real-time reverse transcriptase polymerase chain reaction using formalin-fixed paraffin-embedded tissues.
Kim D; Lee DH; Choi J; Shim KW; Kim SH
Mol Med Rep; 2013 Jan; 7(1):337-41. PubMed ID: 23124437
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts.
Takami H; Elzawahry A; Mamatjan Y; Fukushima S; Fukuoka K; Suzuki T; Yanagisawa T; Matsushita Y; Nakamura T; Satomi K; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Tamura K; Maehara T; Sugiyama K; Yoshimoto K; Sakai K; Nonaka M; Asai A; Yokogami K; Takeshima H; Narita Y; Shibui S; Nakazato Y; Hama N; Totoki Y; Kato M; Shibata T; Nishikawa R; Matsutani M; Ichimura K
Neuro Oncol; 2022 Aug; 24(8):1246-1258. PubMed ID: 35137206
[TBL] [Abstract][Full Text] [Related]
19. Primary Central Nervous System Germ Cell Tumors: A Review and Update.
Fetcko K; Dey M
Med Res Arch; 2018 Mar; 6(3):. PubMed ID: 30271875
[TBL] [Abstract][Full Text] [Related]
20. Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases.
Huang R; Xu X; Li D; Chen K; Zhan Q; Ge M; Zhou X; Liang X; Guan M
Target Oncol; 2019 Jun; 14(3):343-350. PubMed ID: 31161597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]